Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07756671

Photodynamic Therapy For Onychomycosis

Conditions: Onychomycosis of Toenail

Sex: All

Ages: 18 Years – 100 Years

Healthy volunteers: No

Phase: PHASE1

Enrollment: 5

Sponsor: The University of Texas Health Science Center, Houston

Location: Arlington Center for Dermatology Arlington Texas

Summary

The purpose of this study is clinical and mycological clearance of onychomycosis using photodynamic therapy (PDT) with aminolevulinic acid (ALA) 10% gel at 6 months, 3 months, 9 months and 12 months

Eligibility Criteria

Inclusion Criteria: * Clinical and mycological diagnosis \[by potassium hydroxide (KOH) stain\] of onychomycosis Exclusion Criteria: * Known or suspected allergies or sensitivities to any components of any of the study drugs * Patients with coagulation disorders * Known or suspected claustrophobia * Pregnancy during the treatment period * Medically unable to consent * Employees of the clinics * Prisoners

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07756671). StuddyBuddy aggregates publicly available trial information.